DK0895478T3 - Bestanddel B som ardanner - Google Patents
Bestanddel B som ardannerInfo
- Publication number
- DK0895478T3 DK0895478T3 DK96914107T DK96914107T DK0895478T3 DK 0895478 T3 DK0895478 T3 DK 0895478T3 DK 96914107 T DK96914107 T DK 96914107T DK 96914107 T DK96914107 T DK 96914107T DK 0895478 T3 DK0895478 T3 DK 0895478T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- component
- scarring
- sec
- date
- Prior art date
Links
- 230000037390 scarring Effects 0.000 title 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Glass Compositions (AREA)
- External Artificial Organs (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002251356A CA2251356A1 (en) | 1996-04-24 | 1996-04-24 | Component b as cicatrizant |
| PCT/EP1996/001702 WO1997039765A1 (en) | 1996-04-24 | 1996-04-24 | Component b as cicatrizant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0895478T3 true DK0895478T3 (da) | 2003-06-23 |
Family
ID=25680594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96914107T DK0895478T3 (da) | 1996-04-24 | 1996-04-24 | Bestanddel B som ardanner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5998364A (da) |
| EP (1) | EP0895478B1 (da) |
| JP (1) | JP3882943B2 (da) |
| AT (1) | ATE234110T1 (da) |
| AU (1) | AU727618B2 (da) |
| CA (1) | CA2251356A1 (da) |
| DE (1) | DE69626691T2 (da) |
| DK (1) | DK0895478T3 (da) |
| EA (1) | EA001077B1 (da) |
| ES (1) | ES2188754T3 (da) |
| IL (1) | IL120696A (da) |
| NO (1) | NO320611B1 (da) |
| WO (1) | WO1997039765A1 (da) |
| ZA (1) | ZA973442B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1093380T3 (da) * | 1998-07-09 | 2003-01-27 | Applied Research Systems | Komponent B som angiogent middel i kombination med humane vækstfaktorer |
| ATE494903T1 (de) | 2003-04-16 | 2011-01-15 | Merck Serono Sa | Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE53166B1 (en) * | 1980-08-05 | 1988-08-03 | Searle & Co | Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression |
| IT1257184B (it) * | 1992-12-22 | 1996-01-10 | Applied Research Systems | Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale |
-
1996
- 1996-04-24 EA EA199800953A patent/EA001077B1/ru not_active IP Right Cessation
- 1996-04-24 WO PCT/EP1996/001702 patent/WO1997039765A1/en not_active Ceased
- 1996-04-24 JP JP50603797A patent/JP3882943B2/ja not_active Expired - Fee Related
- 1996-04-24 AT AT96914107T patent/ATE234110T1/de not_active IP Right Cessation
- 1996-04-24 US US09/171,659 patent/US5998364A/en not_active Expired - Fee Related
- 1996-04-24 ES ES96914107T patent/ES2188754T3/es not_active Expired - Lifetime
- 1996-04-24 DE DE69626691T patent/DE69626691T2/de not_active Expired - Fee Related
- 1996-04-24 CA CA002251356A patent/CA2251356A1/en not_active Abandoned
- 1996-04-24 DK DK96914107T patent/DK0895478T3/da active
- 1996-04-24 AU AU57605/96A patent/AU727618B2/en not_active Ceased
- 1996-04-24 EP EP96914107A patent/EP0895478B1/en not_active Expired - Lifetime
-
1997
- 1997-04-17 IL IL12069697A patent/IL120696A/en not_active IP Right Cessation
- 1997-04-22 ZA ZA9703442A patent/ZA973442B/xx unknown
-
1998
- 1998-10-23 NO NO19984965A patent/NO320611B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO320611B1 (no) | 2005-12-27 |
| CA2251356A1 (en) | 1997-10-30 |
| NO984965L (no) | 1998-12-01 |
| AU5760596A (en) | 1997-11-12 |
| EP0895478A1 (en) | 1999-02-10 |
| JP3882943B2 (ja) | 2007-02-21 |
| IL120696A0 (en) | 1997-08-14 |
| EP0895478B1 (en) | 2003-03-12 |
| ZA973442B (en) | 1998-02-23 |
| US5998364A (en) | 1999-12-07 |
| DE69626691T2 (de) | 2003-08-14 |
| AU727618B2 (en) | 2000-12-14 |
| IL120696A (en) | 2001-10-31 |
| EA001077B1 (ru) | 2000-10-30 |
| WO1997039765A1 (en) | 1997-10-30 |
| ATE234110T1 (de) | 2003-03-15 |
| EA199800953A1 (ru) | 1999-04-29 |
| NO984965D0 (no) | 1998-10-23 |
| JP2000510436A (ja) | 2000-08-15 |
| ES2188754T3 (es) | 2003-07-01 |
| DE69626691D1 (de) | 2003-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO307027B1 (no) | Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader | |
| TR200102308T2 (tr) | Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı | |
| AU4640997A (en) | Use of an H+, K+-ATPase inhibitor in the treatment of nasal polyps | |
| HU9600887D0 (en) | Compounds for medicinal use | |
| CA2322878A1 (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
| DK0895478T3 (da) | Bestanddel B som ardanner | |
| AU6624996A (en) | Use of betaglycan to reduce scarring | |
| GB9626472D0 (en) | New use of comt inhibitors | |
| ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
| DE59805246D1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
| AU5986498A (en) | Use of aminothiazoles for treating wounds and skin | |
| MD980129A (en) | Antiherpetic remedy | |
| SE9403861D0 (sv) | Novel medicinal use | |
| GB9723824D0 (en) | Cytostatic agents | |
| GB9812278D0 (en) | Use of a wound dressing in the treatment of acute wounds | |
| UA32281A (uk) | Засіб "регенерин" для зовнішнього лікування гнійних ран і трофічних виразок |